Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $2.42 billion. The enterprise value is $2.09 billion.
| Market Cap | 2.42B |
| Enterprise Value | 2.09B |
Important Dates
The last earnings date was Monday, August 3, 2026, before market open.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 58.13 million shares outstanding. The number of shares has increased by 1.67% in one year.
| Current Share Class | 58.13M |
| Shares Outstanding | 58.13M |
| Shares Change (YoY) | +1.67% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 4.49% |
| Owned by Institutions (%) | 98.39% |
| Float | 51.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.87 |
| PS Ratio | 2.92 |
| Forward PS | 2.52 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 5.48 |
| P/FCF Ratio | 128.99 |
| P/OCF Ratio | 121.71 |
| PEG Ratio | 0.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.94, with an EV/FCF ratio of 111.32.
| EV / Earnings | n/a |
| EV / Sales | 2.52 |
| EV / EBITDA | 18.94 |
| EV / EBIT | 239.54 |
| EV / FCF | 111.32 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.08 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 2.14 |
| Interest Coverage | 3.77 |
Financial Efficiency
Return on equity (ROE) is -10.49% and return on invested capital (ROIC) is 1.22%.
| Return on Equity (ROE) | -10.49% |
| Return on Assets (ROA) | 0.39% |
| Return on Invested Capital (ROIC) | 1.22% |
| Return on Capital Employed (ROCE) | 0.81% |
| Weighted Average Cost of Capital (WACC) | 7.26% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$141,242 |
| Employee Count | 778 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.52 |
Taxes
| Income Tax | -13.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.43% in the last 52 weeks. The beta is 0.56, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -9.43% |
| 50-Day Moving Average | 46.39 |
| 200-Day Moving Average | 48.46 |
| Relative Strength Index (RSI) | 31.03 |
| Average Volume (20 Days) | 553,491 |
Short Selling Information
The latest short interest is 4.15 million, so 7.14% of the outstanding shares have been sold short.
| Short Interest | 4.15M |
| Short Previous Month | 4.82M |
| Short % of Shares Out | 7.14% |
| Short % of Float | 8.03% |
| Short Ratio (days to cover) | 4.42 |
Income Statement
In the last 12 months, SUPN had revenue of $830.44 million and -$109.89 million in losses. Loss per share was -$1.91.
| Revenue | 830.44M |
| Gross Profit | 605.31M |
| Operating Income | 8.73M |
| Pretax Income | -123.47M |
| Net Income | -109.89M |
| EBITDA | 110.43M |
| EBIT | 8.73M |
| Loss Per Share | -$1.91 |
Balance Sheet
The company has $372.07 million in cash and $40.17 million in debt, with a net cash position of $331.90 million or $5.71 per share.
| Cash & Cash Equivalents | 372.07M |
| Total Debt | 40.17M |
| Net Cash | 331.90M |
| Net Cash Per Share | $5.71 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 17.73 |
| Working Capital | 376.12M |
Cash Flow
In the last 12 months, operating cash flow was $19.91 million and capital expenditures -$1.12 million, giving a free cash flow of $18.79 million.
| Operating Cash Flow | 19.91M |
| Capital Expenditures | -1.12M |
| Depreciation & Amortization | 101.70M |
| Net Borrowing | n/a |
| Free Cash Flow | 18.79M |
| FCF Per Share | $0.32 |
Margins
Gross margin is 72.89%, with operating and profit margins of 1.05% and -13.23%.
| Gross Margin | 72.89% |
| Operating Margin | 1.05% |
| Pretax Margin | -14.87% |
| Profit Margin | -13.23% |
| EBITDA Margin | 13.30% |
| EBIT Margin | 1.05% |
| FCF Margin | 2.26% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.67% |
| Shareholder Yield | -1.67% |
| Earnings Yield | -4.53% |
| FCF Yield | 0.78% |
Analyst Forecast
The average price target for SUPN is $61.75, which is 48.12% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.75 |
| Price Target Difference | 48.12% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 32.27% |
| EPS Growth Forecast (3Y) | 31.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 5.41 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.41 |
| Piotroski F-Score | 5 |